0001493152-21-021791.txt : 20210901 0001493152-21-021791.hdr.sgml : 20210901 20210901162028 ACCESSION NUMBER: 0001493152-21-021791 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210830 FILED AS OF DATE: 20210901 DATE AS OF CHANGE: 20210901 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Scholtes Bret CENTRAL INDEX KEY: 0001490606 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38861 FILM NUMBER: 211230254 MAIL ADDRESS: STREET 1: 2105 CITY WEST BLVD. STREET 2: SUITE 500 CITY: HOUSTON STATE: TX ZIP: 77042 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Guardion Health Sciences, Inc. CENTRAL INDEX KEY: 0001642375 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 474428421 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 15150 AVENUE OF SCIENCE, SUITE 200 CITY: SAN DIEGO STATE: CA ZIP: 92128 BUSINESS PHONE: (800) 873-5141 MAIL ADDRESS: STREET 1: 15150 AVENUE OF SCIENCE, SUITE 200 CITY: SAN DIEGO STATE: CA ZIP: 92128 FORMER COMPANY: FORMER CONFORMED NAME: Guardion Health Sciences, LLC DATE OF NAME CHANGE: 20150513 4 1 ownership.xml X0306 4 2021-08-30 0 0001642375 Guardion Health Sciences, Inc. GHSI 0001490606 Scholtes Bret C/O GUARDION HEALTH SCIENCES, INC. 2925 RICHMOND AVENUE, SUITE 1200 HOUSTON TX 77098 1 1 0 0 CEO and President Common stock 2021-08-30 4 P 0 4500 1.2568 A 173984 D Common stock 2021-08-31 4 P 0 5500 1.2291 A 179484 D This sales price reflects a weighted average of multiple prices ranging from $1.245 to $1.27. Full information regarding the number of shares sold at each price will be provided to the Securities and Exchange Commission staff, the Issuer or any security holder of the Issuer upon request. This sales price reflects a weighted average of multiple prices ranging from $1.21 to $1.25. Full information regarding the number of shares sold at each price will be provided to the Securities and Exchange Commission staff, the Issuer or any security holder of the Issuer upon request. /s/ Bret Scholtes 2021-09-01